These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23062783)

  • 1. Nurse practitioners: an insight into their integration into Australian community pharmacies.
    McMillan SS; Emmerton L
    Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health.
    Wheeler A; Crump K; Lee M; Li L; Patel A; Yang R; Zhao J; Jensen M
    Res Social Adm Pharm; 2012; 8(3):179-92. PubMed ID: 21831724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of primary care to patients with chronic cough in the community pharmacy setting.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
    Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacy in Australia: a health hub destination of the future.
    McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F
    Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The introduction of the national e-health record into Australian community pharmacy practice: pharmacists' perceptions.
    Mooranian A; Emmerton L; Hattingh L
    Int J Pharm Pract; 2013 Dec; 21(6):405-12. PubMed ID: 23560554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing health literacy practices in a community pharmacy environment: experiences using the AHRQ Pharmacy Health Literacy Assessment Tool.
    O'Neal KS; Crosby KM; Miller MJ; Murray KA; Condren ME
    Res Social Adm Pharm; 2013; 9(5):564-96. PubMed ID: 23267822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
    Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
    Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.
    Swetenham K; Rowett D; Stephenson D
    Aust Health Rev; 2014 May; 38(2):238-41. PubMed ID: 24670916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
    Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.